Avadel Pharmaceuticals recently got 'tentative' FDA approval for its flagship drug. Check out how AVDL investors should navigate this period of uncertainty.
Met FDA-agreed Primary Endpoint with More Nyxol Subjects Gaining 3 Lines of Low Contrast Distance Vision under Dim Light Conditions Compared to Placebo .
Ocuphire Announces Positive Topline Results from LYNX-1 Phase 3 Trial Evaluating Nyxol® Eye Drops for Night Vision Disturbances - read this article along with other careers information, tips and advice on BioSpace
/PRNewswire/ The "mRNA: Therapeutics and Global Markets 2021-2026" report has been added to ResearchAndMarkets.com s offering. The global market for mRNA.
/PRNewswire/ The "mRNA: Therapeutics and Global Markets 2021-2026" report has been added to ResearchAndMarkets.com s offering. The global market for mRNA.